President & CEO
Emerald Health Therapeutics
Bin Huang is an executive leader with over 30 years of experience in life sciences. Ms. Huang's career began with Allelix Crop Technologies, where she spent six years as a plant research scientist. For a number of years Ms. Huang was the president and CEO of Cytovax Biotechnologies, a Canadian biotechnology company. Following that, she led WEX Pharmaceuticals, a subsidiary of publicly listed CK Life Sciences International (Holdings) Inc., as president and CEO. Ms. Huang has a PhD in Plant Cell Biology from the University of East Anglia, UK and an MBA from the University of Toronto.